
    
      This is a single-center, open-label, non-randomized, parallel-controlled Phase I clinical
      study carried out in patients with compensated chronic liver disease (Child-Pugh A), patients
      with decompensated chronic liver disease (Child-Pugh B), and age-, weight-, and
      gender-matched subjects with normal liver functions.
    
  